Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIVETTA: Airway Inflammation in Asthma
NCT06482294Phase 2Active, not recruiting
- Sponsor
- University of Ferrara
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate, beclomethasone dipropionate, budesonide in asthma, sponsored by University of Ferrara. Started Jun 2024; status: active, not recruiting.
02
Drugs
fluticasone propionatebeclomethasone dipropionatebudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06482294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06482294.